{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
NCT03371251: Phase 1/Phase 2 Interventional Completed Systemic Lupus Erythematosus
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:grisnilimab setaritox [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:exlinkibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trontinemab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tecaginlimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mecbotamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02898753: Phase 1/Phase 2 Interventional Terminated Pompe Disease
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:anzurstobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN